31 69

Cited 0 times in

2019 Consensus Korean Diagnostic Guidelines to Define Severity Classification and Treatment Refractoriness for Atopic Dermatitis: Objective and Subjective Assessment of Severity

Authors
 Jung Eun Kim  ;  Min Kyung Shin  ;  Gyeong-Hun Park  ;  Un Ha Lee  ;  Ji Hyun Lee  ;  Tae-Young Han  ;  Hyun Chang Koh  ;  Yong Hyun Jang  ;  Hye One Kim  ;  Chan Ho Na  ;  Bark-Lynn Lew  ;  Ji Young Ahn  ;  Chang Ook Park  ;  Young Joon Seo  ;  Yang Won Lee  ;  Sang Wook Sohn  ;  Young Lip Park 
Citation
 ANNALS OF DERMATOLOGY, Vol.31(6) : 654-661, 2019 
Journal Title
 ANNALS OF DERMATOLOGY 
ISSN
 1013-9087 
Issue Date
2019
Keywords
Consensus ; Dermatitis ; atopic ; Diagnosis ; Guideline ; Treatment failure
Abstract
Background: Systemic immunomodulatory treatment is actively recommended in the treatment for moderate to severe atopic dermatitis (AD) patients. However, consensus criteria for the classification of AD severity or treatment refractoriness have not been established yet. Objective: To establish consensus criteria on the definition of severity classification and treatment refractoriness of AD to provide a basis for proper treatment strategy. Methods: The Korean Atopic Dermatitis Association (KADA) comprised a task force team to establish a definition of moderate to severe AD. A draft of definition of moderate to severe AD was made on the basis of evidence. The recommendation was confirmed by KADA members through a web-based survey. Results: KADA approved that AD with 16≤eczema area and severity index (EASI)<23 should be basically defined as moderate AD whereas AD with EASI score ≥23 should be considered as severe AD. They agreed that it would be reasonable to raise the severity level if patient’s daytime or nighttime pruritus numerical rating scale is equal to or higher than 7 (≥7) or dermatology life quality index score exceeds 10. AD patients who do not reach EASI 50 after appropriate treatment for three months should be considered as a non-responder. Patients with recurrence (EASI ≥16) within three months after cessation of treatment should be considered as a recurrent AD. Conclusion: KADA built a consensus of definition of moderate and severe AD and treatment-refractoriness. These guidelines are expected to help physicians determine proper treatment options in need.
Files in This Item:
T201905230.pdf Download
DOI
10.5021/ad.2019.31.6.654
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Dermatology (피부과학교실) > 1. Journal Papers
Yonsei Authors
Park, Chang Ook(박창욱) ORCID logo https://orcid.org/0000-0003-3856-1201
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/174668
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse